Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 10:15:1398027.
doi: 10.3389/fpsyt.2024.1398027. eCollection 2024.

Craving on the move: targeting smoking memories with a novel 3MDR-smoking cessation protocol

Affiliations

Craving on the move: targeting smoking memories with a novel 3MDR-smoking cessation protocol

Annel P Koomen et al. Front Psychiatry. .

Abstract

Introduction: Improved effectiveness and treatment adherence is needed in smoking cessation (SC) therapies. Another important challenge is to disrupt maladaptive drug-related memories. To achieve these goals, we developed a novel treatment strategy on the basis of motion-assisted memory desensitization and reprocessing (3MDR).

Methods: In this study, the added effect of a distractor task following memory recall during a newly designed 3-day SC version of 3MDR (3MDR-SC) protocol on reducing smoking cue-elicited craving was investigated in abstinent chronic smokers. Chronic smokers were randomly allocated to an active 3MDR-SC group (receiving 3MDR-SC with a working memory distractor task) (n = 42) or a control 3MDR-SC group (receiving 3MDR-SC with a non-distracting task) (n = 39). Smoking cue-induced craving and physiological measures were assessed at baseline (T0) and 1 day after the intervention (T4), and smoking behavior was measured at T0 and 2-week (FU1) and 3-month (FU2) follow-up.

Results: Significant decreases in cue-induced craving from T0 to T4 and daily cigarette use from T0 to FU1 and FU2 were observed but not differ between the two experimental groups. Cue-induced changes in heart-rate variability and skin conductance, which did not differ from T0 to T4, and relapse at FU2 were also not different between groups. Dropout rate during intervention was 2.5%.

Conclusions: The 3-day 3MDR-SC intervention resulted in a reduction in cue-induced craving and smoking behavior and showed very good treatment adherence. There was no added effect of the distractor task on 3MDR-SC efficacy. Further studies, including a treatment as usual control, are needed to confirm 3MDR-SC as an effective SC therapy.

Keywords: EMDR; craving; cue exposure; memory reconsolidation; smoking; smoking cessation; tobacco use disorder; working memory.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
3MDR-SC system setup. Shown are the projection screens (1), projectors (2), safety line (3) for safety harness (4), treadmill (5), safety handrails (6), emergency stop button (7), computer with D-Flow 3MDR software (8), and fume hood (9).
Figure 2
Figure 2
The effect of active 3MDR-SC on cue-induced craving and cue-reactivity. Shown is the mean (+ SD) difference in QSU-brief sum score after cue exposure for all items (A) and reward- and relief-related craving items (B) (n = 75) and of the mean (± SD) RMSSD (C) and mean SCL (D) during the blocks relaxation (R), video (V), picture (P), and handling (H) blocks of the nicotine cue-exposure task (n = 81) at session T0 and T4 in the active 3MDR-SC (red) and control 3MDR-SC (blue) groups. * session, main effect of session of p < 0.05. ** session, main effect of session of p < 0.001. ** block, main effect of block of p < 0.001. R, relaxation; V, video; P, picture; H, handling. Of the HRV data, 10.6% of data points were missing (n = 69), and of the skin conductance data, 6.9% of the data points were missing (n = 45).
Figure 3
Figure 3
The effect of active 3MDR-SC on nicotine dependence severity and daily cigarette use at follow-up. Shown is the mean (± SD) FTND sum score (A) and mean self-reported smoked cigarettes (B) at session T0, FU1, and FU2 in the active 3MDR-SC group (red) and the control 3MDR-SC (blue) group (n = 71). **, main effect of time of p < 0.001.
Figure 4
Figure 4
The effect of active 3MDR-SC on craving for smoking-related personalized pictures directly following treatment and on craving following memory recall of smoking-related cues during treatment. Shown is (A) the mean (+ SD) craving rating at session T0 and T4 for the self-chosen pictures that were selected and not-selected during treatment (n = 76) and (B) mean (± SD) craving at session T1, T2, and T3 at baseline (b) after memory recall by cigarette (c) or personal picture (P1,2) and after the (non-)distractor task (T) (n = 76) in the active 3MD group (red) or the control 3MDR-SC group (blue). * session by phase by group, session by treatment phase by group interaction effect of p < 0.05. * session by group, session by group interaction effect of p < 0.05. ** session by picture type, session by picture type interaction effect of p < 0.001. ** session, main effect of session of p < 0.001. ** picture type, main effect of picture type of p < 0.001. B, baseline; C, puffed cigarette; T, (non-)distractor task; P1, first personalized picture; P2, second personalized picture.

References

    1. World Health Organization . WHO reports on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: World Health Organization; (2021).
    1. European Commission . Tobacco (2020). Available online at: https://health.ec.europa.eu/tobacco/overview_en (Accessed May the 24th, 2023).
    1. Elfeddali I, Bolman C, Candel MJJM, Wiers RW, De Vries H. The role of self-efficacy, recovery self-efficacy, and preparatory planning in predicting short-term smoking relapse. Br J Health Psychol. (2012) 17:185–201. doi: 10.1111/j.2044-8287.2011.02032.x - DOI - PubMed
    1. Moore RA, Aubin HJ. Do placebo response rates from cessation trials inform on strength of addictions? Int J Environ Res Public Health. (2012) 9:192–211. doi: 10.3390/ijerph9010192 - DOI - PMC - PubMed
    1. Chavannes NH, Meijer E, Wind L, van de Graaf RC, Rietbergen C, Croes EA. Richtlijn behandeling van tabaksverslaving en stoppen met roken ondersteuning (herziening). Nederlands tijdschrift voor geneeskunde. (2017) 161:D1394. https://www.trimbos.nl/aanbod/webwinkel/af1580-richtlijn-behandeling-van.... - PubMed

LinkOut - more resources